Log in to save to my catalogue

Single‐domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without i...

Single‐domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without i...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4434607219fc41c0b6465b55049e9dff

Single‐domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors

About this item

Full title

Single‐domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors

Publisher

London: Nature Publishing Group UK

Journal title

EMBO molecular medicine, 2020-04, Vol.12 (4), p.e11298-n/a

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Novel therapies for hemophilia, including non‐factor replacement and
in vivo
gene therapy, are showing promising results in the clinic, including for patients having a history of inhibitor development. Here, we propose a novel therapeutic approach for hemophilia based on llama‐derived single‐domain antibody fragments (sdAbs) able to restore h...

Alternative Titles

Full title

Single‐domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4434607219fc41c0b6465b55049e9dff

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4434607219fc41c0b6465b55049e9dff

Other Identifiers

ISSN

1757-4676

E-ISSN

1757-4684

DOI

10.15252/emmm.201911298

How to access this item